Skip to main content
Clinical Trials/IRCT20200313046756N2
IRCT20200313046756N2
Not Yet Recruiting
Phase 3

a pilot study to Assess the therapeutics indicators in Patients With Acute Myeloid Leukemia Undergoing therapy With deferasirox in Afzalipour Hospital of Kerman

Kerman University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Kerman University of Medical Sciences
Enrollment
40
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age between 18\-65 years
  • AML/non\-AP

Exclusion Criteria

  • HIV infected patients or Hepatitis B,C patients
  • Patients with AML\-induced neurological involvement
  • Patients with uncontrolled blood pressure and heart failure
  • Patients with a history of ocular toxicity due to iron chelators drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials